查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
品牌仿製药市场 - 按药物类别（抗高血压、荷尔蒙、抗代谢物）、应用（肿瘤、心血管疾病）、给药途径（口服、外用）、配销通路（医院药房）、全球预测，2023 - 2032 年
市场调查报告书
商品编码
1368713

品牌仿製药市场 - 按药物类别（抗高血压、荷尔蒙、抗代谢物）、应用（肿瘤、心血管疾病）、给药途径（口服、外用）、配销通路（医院药房）、全球预测，2023 - 2032 年

Branded Generics Market - By Drug Class (Anti-hypertensive, Hormones, Antimetabolites), Application (Oncology, Cardiovascular Diseases), Route of Administration (Oral, Topical), Distribution Channel (Hospital Pharmacy), Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

全球品牌仿製药市场规模将在 2023 年至 2032 年间呈现显着成长。旨在推广仿製药的政府措施可以对市场产生刺激作用。 2023年9月，瑞士政府批准了《健康保险条例》、《医疗保健服务条例》和《药品条例》的修改，计划于2024年1月1日实施。这些修改旨在提高仿製药的成本— —与品牌同行相比，这种方法有效，同时也提高了患者选择更昂贵的选择的共同付款。这项策略性倡议旨在每年节省 2.5 亿瑞士法郎，相当于 2.75 亿美元。

透过鼓励使用更实惠的仿製药替代品，政府政策创造了一个竞争环境，促使製药公司在生产品牌仿製药方面进行创新。这种竞争可以带来更广泛的高品质、具有成本效益的品牌仿製药，透过增加药品市场的选择和潜在的更低价格使消费者受益。

整个品牌仿製药市场根据药物类别、应用、给药途径、配销通路和地区进行分类。

到 2032 年，心血管疾病领域可能会主导品牌仿製药行业的应用领域。患者和医疗保健专业人员通常更喜欢关键药物的值得信赖的品牌，以确保可靠性和品质。此外，品牌仿製药可以提供满足患者偏好和需求的特定配方或给药方法。人们对心血管健康的认识不断增强以及对有效、完善的治疗方法的关注进一步推动了这种需求。

到 2032 年，外用品牌仿製药市场将呈现健康的成长速度。由于其有效性、可负担性和熟悉度，外用品牌仿製药的销售量正在上升。消费者信任知名品牌的皮肤和保健产品，使其成为首选。热门品牌仿製药通常以较低的成本提供与品牌仿製药相同的品质和性能，吸引了注重成本的消费者。人们对皮肤健康的认识不断增强，以及这些值得信赖的替代品的出现，促使它们在市场上越来越受欢迎。

由于几个关键因素，欧洲品牌仿製药产业正在经历强劲成长。欧洲消费者优先考虑品质并信任药品的知名品牌，即使是非专利药品。此外，该地区的医疗保健系统鼓励使用具有成本效益的仿製药，这对患者和政府预算都有好处。监管框架还支持品牌仿製药的成长，为製药公司提供这些值得信赖的替代品创造有利的环境。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：品牌仿製药产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病盛行率上升
      • 过期专利数量不断增加
      • 政府加大力度推广仿製药
    • 产业陷阱与挑战
      • 来自标准仿製药和品牌药的竞争
      • 监管障碍
  • 成长潜力分析
  • COVID-19 影响分析
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：品牌仿製药市场：按药物类别，2018 - 2032 年

  • 主要动向：依药物类别
  • 抗高血压
  • 荷尔蒙
  • 抗代谢药
  • 抗忧郁药
  • 烷基化剂
  • 降血脂药
  • 抗癫痫药
  • 抗精神病药
  • 其他药物类别

第 6 章：品牌仿製药市场：按应用，2018 年 - 2032 年

  • 主要动向：按应用
  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病
  • 胃肠道疾病
  • 皮肤科疾病
  • 急性和慢性疼痛
  • 其他应用

第 7 章：品牌仿製药市场：依管理途径划分，2018 年 - 2032 年

  • 主要动向：按给药途径
  • 口服
  • 专题
  • 注射用
  • 其他给药途径

第 8 章：品牌仿製药市场：按配销通路划分，2018 年 - 2032 年

  • 主要动向：按配销通路
  • 医院药房
  • 零售药房
  • 网路药房

第 9 章：品牌仿製药市场：按地区划分，2018 年 - 2032 年

  • 主要动向：按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 中东和非洲其他地区

第 10 章：公司简介

  • Teva Pharmaceutical Industries Ltd.
  • Lupin
  • Sanofi
  • Sun Pharmaceutical Industries, Ltd.
  • Dr. Reddy's Laboratories Ltd
  • Endo International plc
  • Pfizer, Inc.
  • Viatris, Inc.
  • Abbott Laboratories
  • Sandoz
Product Code: 6565

Global Branded Generics Market size will exhibit an appreciable growth rate between 2023 and 2032. Government initiatives aimed at promoting generic products can have a stimulating effect on the market. In September 2023, the Swiss government approved changes to the Ordinance on Health Insurance, the Ordinance on Health Care Services, and the Ordinance on Medicinal Products, scheduled to be implemented on January 1, 2024. These revisions aim to make generic drugs more cost-effective compared to their brand-name counterparts while also raising patients' co-payments for selecting pricier options. This strategic move is designed to achieve annual savings of CHF 250 million, equivalent to $275 million.

By encouraging the use of more affordable generic alternatives, government policies create a competitive environment, prompting pharmaceutical companies to innovate in producing branded generic products. This competition can lead to a wider range of high-quality, cost-effective branded generics, benefiting consumers with increased choices and potentially lower prices in the pharmaceutical market.

The overall branded generics market is categorized based on drug class, application, route of administration, distribution channel, and region.

The cardiovascular disease segment could dominate the application landscape of the branded generics industry by 2032. Patients and healthcare professionals often prefer trusted brand names for critical medications, ensuring reliability and quality. Additionally, branded generics may offer specific formulations or delivery methods that cater to patient preferences and needs. This demand is further propelled by a growing awareness of cardiovascular health and a focus on effective, well-established treatments.

Topical branded generics market will demonstrate a healthy growth rate through 2032. Sales of topical branded generics are on the rise due to their effectiveness, affordability, and familiarity. Consumers trust well-known brand names for skin and healthcare products, making them a preferred choice. Topical branded generics often offer the same quality and performance as their brand-name counterparts at a lower cost, appealing to cost-conscious consumers. The increasing awareness of skin health and the availability of these trusted alternatives contribute to their growing popularity in the market.

Europe branded generics industry is experiencing robust growth due to several key factors. European consumers prioritize quality and trust established brand names for pharmaceuticals, even in generic forms. Additionally, healthcare systems in the region encourage the use of cost-effective generics, benefiting both patients and government budgets. Regulatory frameworks also support the growth of branded generics, creating a favorable environment for pharmaceutical companies to offer these trusted alternatives.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Branded generics industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Drug class trends
    • 2.1.4 Application trends
    • 2.1.5 Route of administration trends
    • 2.1.6 Distribution channel trends

Chapter 3 Branded Generics Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence rate of chronic diseases
      • 3.2.1.2 Rising number of expired patents
      • 3.2.1.3 Increasing government initiatives to promote generic products
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Competition from standard generics and brand-name drugs
      • 3.2.2.2 Regulatory barriers
  • 3.3 Growth potential analysis
    • 3.3.1 By drug class
    • 3.3.2 By application
    • 3.3.3 By route of administration
    • 3.3.4 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Branded Generics Market, By Drug Class, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by drug class
  • 5.2 Anti-hypertensive
  • 5.3 Hormones
  • 5.4 Antimetabolites
  • 5.5 Anti-depressants
  • 5.6 Alkylating agents
  • 5.7 Lipid lowering drugs
  • 5.8 Anti-epileptics
  • 5.9 Anti-psychotics
  • 5.10 Other drug classes

Chapter 6 Branded Generics Market, By Application, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Oncology
  • 6.3 Cardiovascular diseases
  • 6.4 Neurological diseases
  • 6.5 Gastrointestinal diseases
  • 6.6 Dermatological diseases
  • 6.7 Acute & chronic pain
  • 6.8 Other applications

Chapter 7 Branded Generics Market, By Route of Administration, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Oral
  • 7.3 Topical
  • 7.4 Parenteral
  • 7.5 Other routes of administration

Chapter 8 Branded Generics Market, By Distribution Channel, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacy
  • 8.3 Retail pharmacy
  • 8.4 Online pharmacy

Chapter 9 Branded Generics Market, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Teva Pharmaceutical Industries Ltd.
  • 10.2 Lupin
  • 10.3 Sanofi
  • 10.4 Sun Pharmaceutical Industries, Ltd.
  • 10.5 Dr. Reddy's Laboratories Ltd
  • 10.6 Endo International plc
  • 10.7 Pfizer, Inc.
  • 10.8 Viatris, Inc.
  • 10.9 Abbott Laboratories
  • 10.10 Sandoz

Data Tables

  • TABLE 1 Market revenue, by drug class (2022)
  • TABLE 2 Market revenue, by route of administration (2022)
  • TABLE 3 Market share, by application (2022)
  • TABLE 4 Market share, by distribution channel (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global branded generics market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global branded generics market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 9 Global branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 10 Global branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 11 Global branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 12 Global branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 13 Global branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 14 Global branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 15 Global branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 16 Industry impact forces
  • TABLE 17 Anti-hypertensive market size, 2018 - 2022 (USD Million)
  • TABLE 18 Anti-hypertensive market size, 2023 - 2032 (USD Million)
  • TABLE 19 Hormones market size, 2018 - 2022 (USD Million)
  • TABLE 20 Hormones market size, 2023 - 2032 (USD Million)
  • TABLE 21 Antimetabolites market size, 2018 - 2022 (USD Million)
  • TABLE 22 Antimetabolites market size, 2023 - 2032 (USD Million)
  • TABLE 23 Anti-depressants market size, 2018 - 2022 (USD Million)
  • TABLE 24 Anti-depressants market size, 2023 - 2032 (USD Million)
  • TABLE 25 Alkylating agents market size, 2018 - 2022 (USD Million)
  • TABLE 26 Alkylating agents market size, 2023 - 2032 (USD Million)
  • TABLE 27 Lipid lowering drugs market size, 2018 - 2022 (USD Million)
  • TABLE 28 Lipid lowering drugs market size, 2023 - 2032 (USD Million)
  • TABLE 29 Anti-epileptics market size, 2018 - 2022 (USD Million)
  • TABLE 30 Anti-epileptics market size, 2023 - 2032 (USD Million)
  • TABLE 31 Anti-psychotics market size, 2018 - 2022 (USD Million)
  • TABLE 32 Anti-psychotics market size, 2023 - 2032 (USD Million)
  • TABLE 33 Other drug classes market size, 2018 - 2022 (USD Million)
  • TABLE 34 Other drug classes market size, 2023 - 2032 (USD Million)
  • TABLE 35 Oncology market size, 2018 - 2022 (USD Million)
  • TABLE 36 Oncology market size, 2023 - 2032 (USD Million)
  • TABLE 37 Cardiovascular diseases market size, 2018 - 2022 (USD Million)
  • TABLE 38 Cardiovascular diseases market size, 2023 - 2032 (USD Million)
  • TABLE 39 Neurological diseases market size, 2018 - 2022 (USD Million)
  • TABLE 40 Neurological diseases market size, 2023 - 2032 (USD Million)
  • TABLE 41 Gastrointestinal diseases market size, 2018 - 2022 (USD Million)
  • TABLE 42 Gastrointestinal diseases market size, 2023 - 2032 (USD Million)
  • TABLE 43 Dermatological diseases market size, 2018 - 2022 (USD Million)
  • TABLE 44 Dermatological diseases market size, 2023 - 2032 (USD Million)
  • TABLE 45 Acute & chronic pain market size, 2018 - 2022 (USD Million)
  • TABLE 46 Acute & chronic pain market size, 2023 - 2032 (USD Million)
  • TABLE 47 Other applications market size, 2018 - 2022 (USD Million)
  • TABLE 48 Other applications market size, 2023 - 2032 (USD Million)
  • TABLE 49 Oral market size, 2018 - 2022 (USD Million)
  • TABLE 50 Oral market size, 2023 - 2032 (USD Million)
  • TABLE 51 Topical market size, 2018 - 2022 (USD Million)
  • TABLE 52 Topical market size, 2023 - 2032 (USD Million)
  • TABLE 53 Parenteral market size, 2018 - 2022 (USD Million)
  • TABLE 54 Parenteral market size, 2023 - 2032 (USD Million)
  • TABLE 55 Other routes of administration market size, 2018 - 2022 (USD Million)
  • TABLE 56 Other routes of administration market size, 2023 - 2032 (USD Million)
  • TABLE 57 Hospital pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 58 Hospital pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 59 Retail pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 60 Retail pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 61 Online pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 62 Online pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 63 North America branded generics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 64 North America branded generics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 65 North America branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 66 North America branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 67 North America branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 68 North America branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 69 North America branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 70 North America branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 71 North America branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 72 North America branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 73 U.S. branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 74 U.S. branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 75 U.S. branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 76 U.S. branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 77 U.S. branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 78 U.S. branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 79 U.S. branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 80 U.S. branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 81 Canada branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 82 Canada branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 83 Canada branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 84 Canada branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 85 Canada branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 86 Canada branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 87 Canada branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 88 Canada branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 89 Europe branded generics Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 90 Europe branded generics Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 91 Europe branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 92 Europe branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 93 Europe branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 94 Europe branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 95 Europe branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 96 Europe branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 97 Europe branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 98 Europe branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 99 Germany branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 100 Germany branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 101 Germany branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 102 Germany branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 103 Germany branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 104 Germany branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 105 Germany branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 106 Germany branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 107 UK branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 108 UK branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 109 UK branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 110 UK branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 111 UK branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 112 UK branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 113 UK branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 114 UK branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 115 France branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 116 France branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 117 France branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 118 France branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 119 France branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 120 France branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 121 France branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 122 France branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 123 Spain branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 124 Spain branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 125 Spain branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 126 Spain branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 127 Spain branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 128 Spain branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 129 Spain branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 130 Spain branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 131 Italy branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 132 Italy branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 133 Italy branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 134 Italy branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 135 Italy branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 136 Italy branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 137 Italy branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 138 Italy branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 139 Rest of Europe branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 140 Rest of Europe branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 141 Rest of Europe branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 142 Rest of Europe branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 143 Rest of Europe branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 144 Rest of Europe branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 145 Rest of Europe branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 146 Rest of Europe branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 147 Asia Pacific branded generics Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 148 Asia Pacific branded generics Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 149 Asia Pacific branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 150 Asia Pacific branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 151 Asia Pacific branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 152 Asia Pacific branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 153 Asia Pacific branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 154 Asia Pacific branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 155 Asia Pacific branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 156 Asia Pacific branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 157 Japan branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 158 Japan branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 159 Japan branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 160 Japan branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 161 Japan branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 162 Japan branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 163 Japan branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 164 Japan branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 165 China branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 166 China branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 167 China branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 168 China branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 169 China branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 170 China branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 171 China branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 172 China branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 173 India branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 174 India branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 175 India branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 176 India branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 177 India branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 178 India branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 179 India branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 180 India branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 181 Australia branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 182 Australia branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 183 Australia branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 184 Australia branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 185 Australia branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 186 Australia branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 187 Australia branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 188 Australia branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 189 Rest of Asia Pacific branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 190 Rest of Asia Pacific branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 191 Rest of Asia Pacific branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 192 Rest of Asia Pacific branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 193 Rest of Asia Pacific branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 194 Rest of Asia Pacific branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 195 Rest of Asia Pacific branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 196 Rest of Asia Pacific branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 197 Latin America branded generics Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 198 Latin America branded generics Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 199 Latin America branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 200 Latin America branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 201 Latin America branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 202 Latin America branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 203 Latin America branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 204 Latin America branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 205 Latin America branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 206 Latin America branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 207 Brazil branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 208 Brazil branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 209 Brazil branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 210 Brazil branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 211 Brazil branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 212 Brazil branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 213 Brazil branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 214 Brazil branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 215 Mexico branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 216 Mexico branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 217 Mexico branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 218 Mexico branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 219 Mexico branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 220 Mexico branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 221 Mexico branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 222 Mexico branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 223 Rest of Latin America branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 224 Rest of Latin America branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 225 Rest of Latin America branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 226 Rest of Latin America branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 227 Rest of Latin America branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 228 Rest of Latin America branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 229 Rest of Latin America branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 230 Rest of Latin America branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 231 Middle East & Africa branded generics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 232 Middle East & Africa branded generics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 233 Middle East & Africa branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 234 Middle East & Africa branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 235 Middle East & Africa branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 236 Middle East & Africa branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 237 Middle East & Africa branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 238 Middle East & Africa branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 239 Middle East & Africa branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 240 Middle East & Africa branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 241 Saudi Arabia branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 242 Saudi Arabia branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 243 Saudi Arabia branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 244 Saudi Arabia branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 245 Saudi Arabia branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 246 Saudi Arabia branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 247 Saudi Arabia branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 248 Saudi Arabia branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 249 South Africa branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 250 South Africa branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 251 South Africa branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 252 South Africa branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 253 South Africa branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 254 South Africa branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 255 South Africa branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 256 South Africa branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 257 Rest of Middle East and Africa branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 258 Rest of Middle East and Africa branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 259 Rest of Middle East and Africa branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 260 Rest of Middle East and Africa branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 261 Rest of Middle East and Africa branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 262 Rest of Middle East and Africa branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 263 Rest of Middle East and Africa branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 264 Rest of Middle East and Africa branded generics market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Branded generics industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug class
  • FIG 8 Growth potential analysis, by route of administration
  • FIG 9 Growth potential analysis, by application
  • FIG 10 Growth potential analysis, by distribution channel
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Competitive analysis of major market players, 2022
  • FIG 15 Competitive positioning matrix
  • FIG 16 Strategic dashboard, 2022